• Title of article

    Association of CYP3A4 and CYP3A5 polymorphisms with Iranian breast cancer patients

  • Author/Authors

    badavi, e. ahvaz jundishapur university of medical sciences - school of pharmacy, toxicology research center - dept of pharmacology and toxicology, اهواز, ايران , safavi, b. shahid chamran university of ahvaz - school of sciences - dept of genetics, اهواز, ايران , jalali, a. ahvaz jundishapur university of medical sciences - school of pharmacy and toxicology research center - dept of pharmacology and toxicology, اهواز, ايران , shahriary, g.m. shahid chamran university of ahvaz - school of sciences - dept of genetics, اهواز, ايران , mohammadi-asl, j. ahvaz jundishapur university of medical sciences - faculty of medicine - dept of medical genetics, اهواز, ايران , babaei, j. ahvaz jundishapur university of medical sciences - school of pharmacy and toxicology research center - dept of pharmacology and toxicology, اهواز, ايران

  • From page
    219
  • To page
    225
  • Abstract
    Background: Polymorphisms of different gene have been reported to be associated with cancer including breast cancer. Hospitalization rate for breast cancer has increased over the years in Iran. Aim: The aim of this study was to examine whether polymorphisms in the CYP3A4 and CYP3A5 genes affect the risk of developing breast cancer. Subjects and methods: The genotype distribution and allele frequencies of four CYP3A4*1A,CYP3A4*1B,CYP3A5*1 and CYP3A5*3 single-nucleotide polymorphisms were determined in 250 subjects from the general population in Ahvaz city (southwest of Iran) including 200 healthy subjects and 50 individuals affected with breast cancer. Results and conclusion: The genotype frequency of CYP3A4*. 1A/*. 1A (A/A) in both case and control groups was 100%; however,there was no subject with either CYP3A4*. 1A/*. 1B (A/G) or CYP3A4*. 1B/*. 1B (G/G) genotype. For CYP3A5 gene,CYP3A5*. 3/*. 3mutant homozygote genotype frequency was found to be 99% (. n=. 198) and 98% (n = 49) in control and patient groups respectively. CYP3A5*. 1/*. 1 wild-type genotype was calculated to be 1% (n = 2) in the control group and 2% (n = 1) in the case group. No. CYP3A5*. 1/*. 3 heterozygote genotype was detected in the both groups. The results showed that there was no association between breast cancer,CYP3A5 (P-value = 0.561) and CYP3A4 allele distribution. © 2015 The Authors. Production and hosting by Elsevier B.V.
  • Keywords
    Breast cancer , CYP3A4 , CYP3A5 , Iranian population , Polymorphism
  • Journal title
    Egyptian Journal of Medical Human Genetics
  • Journal title
    Egyptian Journal of Medical Human Genetics
  • Record number

    2721174